Q2 2024 Earnings Remarks (Q2 2024 Earnings Results Supplement)
Ares Management Fund Announces Strategic Investment in Belo Medical Group
Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary[...]
07/29/2024 | Press release | Distributed by Public on 07/29/2024 04:34
Please select the service you want to use:
Smartlinks | Revvity Inc. | News | Health | Finance | Security Markets | Security Markets | Company News | Corporate Debt | Securities Issuers | Medical Supplies and Equipment Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Sao Paulo Stock Exchange (B3) | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Bolsa Mexicana de Valores (BMV) | Moscow Exchange (MOEX) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe Off Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Bolsa Institucional de Valores (BIVA) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact